Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA clears Polaryx's IND for PLX-200 in juvenile neuronal ceroid lipofuscinosis

April 8, 2020

Crinetics reports interim data from phase II ACROBAT EDGE trial of paltusotine in acromegaly

April 7, 2020

European Commission approves Nilemdo and Nustendi

April 7, 2020

Millendo Therapeutics discontinues development of livoletide for PWS

April 7, 2020

GRASP55 plays a key physiological role in intestinal lipid uptake

April 7, 2020

European Commission approves Rybelsus for type 2 diabetes

April 6, 2020

Crinetics Pharmaceuticals presents somatostatin SST2 receptor agonists

April 3, 2020

Females, males have different metabolic response to intermittent fasting

April 3, 2020

New melanocortin MC4 receptor agonists synthesized at Novo Nordisk

March 31, 2020

Lamin A/C's presence in nucleus, absence from membrane both problematic in progeria

March 31, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
In the clinic for July 17, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: AMT, Innocare, Insmed, Syntis, Telo Genomics.